FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2584719542> ?p ?o ?g. }

• W2584719542 endingPage "386" @default.
• W2584719542 startingPage "386" @default.
• W2584719542 abstract "Abstract Abstract 386 Aberrant genomic DNA methylation patterns are widely reported in human cancers but the prognostic value and pathological consequences of these marks remain uncertain. CpG methylation is catalyzed by a family of DNA methyltransferase enzymes comprised of three members – Dnmt1, Dnmt3a and Dnmt3b. Mutations in the de novo DNA methyltransferase enzyme DNMT3A have now been reported in over 20% of adult acute myeloid leukemia (AML) and 10–15% of myelodysplastic syndrome (MDS) patients. However, analysis of promoter methylation and gene expression in these patients has thus far failed to yield any mechanistic insight into the pathology of DNMT3A mutation-driven leukemia. In this study, we have used a conditional knockout mouse model to study the role of Dnmt3a in normal hematopoiesis. Hematopoietic stem cells (HSCs) from Mx1-Cre:Dnmt3afl/fl mice were serially transplanted into lethally irradiated recipient mice to study the effect of loss of Dnmt3a on HSC self-renewal and differentiation. We show that loss of Dnmt3a progressively impedes HSC differentiation over four-rounds of serial transplantation, while simultaneously expanding HSC numbers in the bone marrow. Examination of the bone marrow post-transplant revealed that control HSCs showed a gradual decline in their ability to regenerate the HSC pool at each successive round of transplantation, while in contrast Dnmt3a-KO HSCs show a remarkably robust capacity for amplification, generating 40,000 – 100,000 HSCs per mouse. Quantification of peripheral blood differentiation on a per HSC basis demonstrated in the absence of Dnmt3a, a cell division is more likely to result in a self-renewal rather than differentiation fate (Figure 1). Using semi-global reduced representation bisulfite sequencing (RRBS), we show that Dnmt3a-KO HSCs manifest both increased and decreased methylation at distinct loci, including dramatic CpG island hypermethylation. Global transcriptional analysis by microarray revealed that Dnmt3a-KO HSCs show upregulation of HSC multipotency genes coupled with simultaneous downregulation of early differentiation factors (e.g. Flt3, PU.1, Mef2c), likely inhibiting the initial stages of HSC differentiation. Upregulation of key HSC regulators including Runx1, Gata3 and Nr4a2 was associated with gene-body hypomethylation and activated chromatin marks (H3K4me3) in Dnmt3a-KO HSCs. Finally, we show that Dnmt3a-KO HSCs are unable to methylate and transcriptionally repress these key HSC multipotency genes in response to chemotherapeutic ablation of the hematopoietic system, leading to inefficient differentiation and manifesting hypomethylation and incomplete repression of HSC-specific genes in their limited differentiated progeny. In conclusion, we show that Dnmt3a plays a specific role in permitting HSC differentiation, as in its absence, phenotypically normal but impotent stem cells accumulate and differentiation capacity is progressively lost. This differentiation-deficit phenotype is reminiscent of Dnmt3a/Dnmt3b-null embryonic stem (ES) cells while markedly distinct from that of Dnmt1-KO HSCs which show premature HSC exhaustion and lymphoid-deficient differentiation, demonstrating distinct roles for the different DNA methyltransferase enzymes in HSCs. In light of the recently-identified DNMT3A mutations in AML and MDS patients, these studies are the first biological models linking mutation of Dnmt3a with inhibition of HSC differentiation which may be one of the first pathogenic steps occuring in such patients.Figure 1Dnmt3a-KO HSCs become biased towards self-renewal as opposed to differentiation. At each transplant round, the self-renewal quotient was calculated as the number of donor-derived HSCs recovered at the end of the transplant divided by 250 (the number of HSC initially transplanted). The differentiation quotient was calculated as (the white blood cell count per μl of blood at 16 weeks) X (percentage of donor-cell chimerism)/number of donor HSC at the end of the transplant. Over serial transfer, Dnmt3a-KO HSCs more rapidly lose their differentiation capacity compared to control HSCs, while sustaining robust self-renewal.Figure 1. Dnmt3a-KO HSCs become biased towards self-renewal as opposed to differentiation. At each transplant round, the self-renewal quotient was calculated as the number of donor-derived HSCs recovered at the end of the transplant divided by 250 (the number of HSC initially transplanted). The differentiation quotient was calculated as (the white blood cell count per μl of blood at 16 weeks) X (percentage of donor-cell chimerism)/number of donor HSC at the end of the transplant. Over serial transfer, Dnmt3a-KO HSCs more rapidly lose their differentiation capacity compared to control HSCs, while sustaining robust self-renewal. Disclosures: Issa: Novartis: Honoraria; GSK: Consultancy; SYNDAX: Consultancy; Merck: Research Funding; Eisai: Research Funding; Celgene: Research Funding; Celgene: Honoraria; J&J: Honoraria." @default.
• W2584719542 created "2017-02-10" @default.
• W2584719542 creator A5013266798 @default.
• W2584719542 creator A5023473953 @default.
• W2584719542 creator A5027336256 @default.
• W2584719542 creator A5031703305 @default.
• W2584719542 creator A5054185434 @default.
• W2584719542 creator A5065240782 @default.
• W2584719542 creator A5066248565 @default.
• W2584719542 creator A5068486677 @default.
• W2584719542 creator A5072707191 @default.
• W2584719542 creator A5074463940 @default.
• W2584719542 creator A5088202206 @default.
• W2584719542 date "2011-11-18" @default.
• W2584719542 modified "2023-09-27" @default.
• W2584719542 title "Dnmt3a Is Essential for Hematopoietic Stem Cell Differentiation" @default.
• W2584719542 cites W1577875429 @default.
• W2584719542 cites W1968717432 @default.
• W2584719542 cites W1970224079 @default.
• W2584719542 cites W1971833736 @default.
• W2584719542 cites W1984850507 @default.
• W2584719542 cites W2003336545 @default.
• W2584719542 cites W2004313287 @default.
• W2584719542 cites W2009847666 @default.
• W2584719542 cites W2010318973 @default.
• W2584719542 cites W2011221227 @default.
• W2584719542 cites W2012860082 @default.
• W2584719542 cites W2015735089 @default.
• W2584719542 cites W2016536941 @default.
• W2584719542 cites W2018304597 @default.
• W2584719542 cites W2021539006 @default.
• W2584719542 cites W2021836517 @default.
• W2584719542 cites W2045000380 @default.
• W2584719542 cites W2048365283 @default.
• W2584719542 cites W2058537378 @default.
• W2584719542 cites W2059099579 @default.
• W2584719542 cites W2060446375 @default.
• W2584719542 cites W2072411272 @default.
• W2584719542 cites W2073154819 @default.
• W2584719542 cites W2085033687 @default.
• W2584719542 cites W2085561926 @default.
• W2584719542 cites W2088621765 @default.
• W2584719542 cites W2089242137 @default.
• W2584719542 cites W2093958228 @default.
• W2584719542 cites W2094783645 @default.
• W2584719542 cites W2106889224 @default.
• W2584719542 cites W2108664872 @default.
• W2584719542 cites W2123480703 @default.
• W2584719542 cites W2130826348 @default.
• W2584719542 cites W2131072337 @default.
• W2584719542 cites W2137956382 @default.
• W2584719542 cites W2140929811 @default.
• W2584719542 cites W2141554152 @default.
• W2584719542 cites W2142711018 @default.
• W2584719542 cites W2149790281 @default.
• W2584719542 cites W2157896232 @default.
• W2584719542 cites W2161224111 @default.
• W2584719542 cites W2167319166 @default.
• W2584719542 cites W2593754012 @default.
• W2584719542 doi "https://doi.org/10.1182/blood.v118.21.386.386" @default.
• W2584719542 hasPublicationYear "2011" @default.
• W2584719542 type Work @default.
• W2584719542 sameAs 2584719542 @default.
• W2584719542 citedByCount "5" @default.
• W2584719542 countsByYear W25847195422016 @default.
• W2584719542 countsByYear W25847195422020 @default.
• W2584719542 countsByYear W25847195422021 @default.
• W2584719542 countsByYear W25847195422022 @default.
• W2584719542 countsByYear W25847195422023 @default.
• W2584719542 crossrefType "journal-article" @default.
• W2584719542 hasAuthorship W2584719542A5013266798 @default.
• W2584719542 hasAuthorship W2584719542A5023473953 @default.
• W2584719542 hasAuthorship W2584719542A5027336256 @default.
• W2584719542 hasAuthorship W2584719542A5031703305 @default.
• W2584719542 hasAuthorship W2584719542A5054185434 @default.
• W2584719542 hasAuthorship W2584719542A5065240782 @default.
• W2584719542 hasAuthorship W2584719542A5066248565 @default.
• W2584719542 hasAuthorship W2584719542A5068486677 @default.
• W2584719542 hasAuthorship W2584719542A5072707191 @default.
• W2584719542 hasAuthorship W2584719542A5074463940 @default.
• W2584719542 hasAuthorship W2584719542A5088202206 @default.
• W2584719542 hasBestOaLocation W25847195422 @default.
• W2584719542 hasConcept C10205521 @default.
• W2584719542 hasConcept C104317684 @default.
• W2584719542 hasConcept C109159458 @default.
• W2584719542 hasConcept C126322002 @default.
• W2584719542 hasConcept C150194340 @default.
• W2584719542 hasConcept C190727270 @default.
• W2584719542 hasConcept C203014093 @default.
• W2584719542 hasConcept C2778086970 @default.
• W2584719542 hasConcept C2778461978 @default.
• W2584719542 hasConcept C2779282312 @default.
• W2584719542 hasConcept C2779979206 @default.
• W2584719542 hasConcept C2780007613 @default.
• W2584719542 hasConcept C28328180 @default.
• W2584719542 hasConcept C2911091166 @default.
• W2584719542 hasConcept C502942594 @default.
• W2584719542 hasConcept C54355233 @default.

• next